HMOX1 and diabetes mellitus: The fluorescence intensity increased with increasing drug loading, with tissues samples from animals treated with DPFI-3 showing fluorescence intensities for CD163 and HO-1 that were 25.7 and 28.7 times higher than those observed in the diabetes group, respectively.